Literature DB >> 12865327

Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-alpha protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary.

Elaine T Alarid1, Mara T Preisler-Mashek, Natalia M Solodin.   

Abstract

Proteolysis by the 26S proteasome is an important regulatory mechanism that governs the protein stability of several steroid/nuclear receptors and that has been implicated in the control of receptor transcriptional activation function. Herein, we report that thyroid hormone can prevent estrogen-induced proteolysis of estrogen receptor-alpha (ERalpha) protein in lactotrope cells of the pituitary. The stabilization of ERalpha protein by thyroid hormone represents a selective blockade against estradiol-stimulated degradation, because thyroid hormone (but not glucocorticoid) can protect estrogen-activated ERalpha. Moreover, thyroid hormone treatment does not interfere with signal-induced proteolysis of a separate proteasome target, IkappaBalpha or ERalpha proteolysis induced by ICI182780. Using thyroid hormone as a tool to inhibit ERalpha proteolysis, we examined the effect of loss of this regulatory function on estrogen-induced transcriptional responses. Consistent with earlier reports, estrogen activation of an idealized estrogen response element reporter gene was inhibited. However, thyroid hormone did not prevent induction of prolactin gene expression or the ability of ERalpha to stimulate proliferation. These results demonstrate that estrogen-induced proteolysis of ERalpha is not a general requirement for receptor transcriptional activation function, and they demonstrate that proteolytic regulation is a means by which other endocrine factors can indirectly modulate ERalpha activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12865327     DOI: 10.1210/en.2002-0092

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  Thyroid hormone can increase estrogen-mediated transcription from a consensus estrogen response element in neuroblastoma cells.

Authors:  Xing Zhao; Heather Lorenc; Heather Stephenson; Yunjiao Joy Wang; Dawn Witherspoon; Benita Katzenellenbogen; Donald Pfaff; Nandini Vasudevan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-18       Impact factor: 11.205

2.  Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus.

Authors:  Christopher C Valley; Raphaël Métivier; Natalia M Solodin; Amy M Fowler; Mara T Mashek; Lindsay Hill; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer.

Authors:  A Rodriguez-Gonzalez; K Cyrus; M Salcius; K Kim; C M Crews; R J Deshaies; K M Sakamoto
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

Review 4.  Back to your heart: ubiquitin proteasome system-regulated signal transduction.

Authors:  Andrea L Portbury; Sarah M Ronnebaum; Makhosazane Zungu; Cam Patterson; Monte S Willis
Journal:  J Mol Cell Cardiol       Date:  2011-11-06       Impact factor: 5.000

5.  Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.

Authors:  Haibo Liu; Jianming Qiu; Nan Li; Taoyong Chen; Xuetao Cao
Journal:  J Biol Chem       Date:  2010-05-11       Impact factor: 5.157

6.  Roles of ERK1/2 and PI3K/AKT signaling pathways in mitochondria-mediated apoptosis in testes of hypothyroid rats.

Authors:  Yueli Yao; Xiaoru Chang; Dong Wang; Haitao Ma; Huiling Wang; Haojun Zhang; Chengyun Li; Junling Wang
Journal:  Toxicol Res (Camb)       Date:  2018-08-27       Impact factor: 3.524

7.  A case-control study of levothyroxine and the risk of colorectal cancer.

Authors:  Gad Rennert; Hedy S Rennert; Mila Pinchev; Stephen B Gruber
Journal:  J Natl Cancer Inst       Date:  2010-03-19       Impact factor: 13.506

8.  ERα phosphorylation at Y537 by Src triggers E6-AP-ERα binding, ERα ubiquitylation, promoter occupancy, and target gene expression.

Authors:  Jun Sun; Wen Zhou; Kosalai Kaliappan; Zafar Nawaz; Joyce M Slingerland
Journal:  Mol Endocrinol       Date:  2012-08-03

9.  Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.

Authors:  Isabel Chu; Angel Arnaout; Sophie Loiseau; Jun Sun; Arun Seth; Chris McMahon; Kathy Chun; Bryan Hennessy; Gordon B Mills; Zafar Nawaz; Joyce M Slingerland
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

10.  Ligand-induced estrogen receptor alpha degradation by the proteasome: new actors?

Authors:  Mathilde Calligé; Hélène Richard-Foy
Journal:  Nucl Recept Signal       Date:  2006-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.